30
Participants
Start Date
February 16, 2024
Primary Completion Date
February 16, 2024
Study Completion Date
April 30, 2024
Percutaneous neuromodulation
Patients will receive a needle circuit approaching the deep peroneal nerve in an echoguided manner. They will receive a symmetrical biphasic current of 20-30Hz and 250 μs at tolerable intensity.
Transcutaneous neuromodulation
Patients will have a superficial electrode circuit placed over the belly of the tibialis anterior muscle. They will receive a symmetrical biphasic current of 20-30Hz and 250 μs at tolerable intensity.
Placebo-percutaneous
Patients will have the neuromodulation circuit placed with needles at 0 intensity, approaching the deep peroneal nerve in an ultrasound-guided manner.
Placebo-transcutaneous
patients will have the electrodes placed over the tibialis anterior muscle at intensity 0.
Percutaneous neuromodulation or Transcutaneous neuromodulation (optional)
Study participants who wish to continue may be randomized to receive a 10-session intervention program. The intervention to be received will consist of 10 sessions of percutaneous neuromodulation or 10 sessions of transcutaneous neuromodulation, two sessions per week.
Mª Dolores Apolo Arenas, Badajoz
University of Extremadura
OTHER